Lesley A. Inker

56.1k total citations · 9 hit papers
221 papers, 14.1k citations indexed

About

Lesley A. Inker is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lesley A. Inker has authored 221 papers receiving a total of 14.1k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Nephrology, 53 papers in Cardiology and Cardiovascular Medicine and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lesley A. Inker's work include Chronic Kidney Disease and Diabetes (126 papers), Dialysis and Renal Disease Management (95 papers) and Renal Diseases and Glomerulopathies (41 papers). Lesley A. Inker is often cited by papers focused on Chronic Kidney Disease and Diabetes (126 papers), Dialysis and Renal Disease Management (95 papers) and Renal Diseases and Glomerulopathies (41 papers). Lesley A. Inker collaborates with scholars based in United States, Netherlands and Germany. Lesley A. Inker's co-authors include Andrew S. Levey, Josef Coresh, Hocine Tighiouart, Tom Greene, Harold I. Feldman, John H. Eckfeldt, Christopher H. Schmid, John W. Kusek, Frederick Van Lente and Brad C. Astor and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Lesley A. Inker

209 papers receiving 13.9k citations

Hit Papers

Estimating Glomerular Filtration Rate from Serum Creatini... 2012 2026 2016 2021 2012 2014 2013 2021 2015 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
    2012 3.0k citations Lesley A. Inker, Hocine Tighiouart et al. profile →
  2. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD
    2014 1.2k citations Lesley A. Inker et al. profile →
  3. Cystatin C versus Creatinine in Determining Risk Based on Kidney Function
    2013 643 citations Michael G. Shlipak, Lesley A. Inker et al. profile →
  4. A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease
    2021 424 citations Cynthia Delgado, Mukta Baweja et al. profile →
  5. Glomerular Filtration Rate and Albuminuria for Detection and Staging of Acute and Chronic Kidney Disease in Adults
    2015 419 citations Andrew S. Levey, Lesley A. Inker et al. profile →
  6. GFR Estimation: From Physiology to Public Health
    2014 406 citations Andrew S. Levey, Lesley A. Inker et al. profile →
  7. GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
    2014 389 citations Andrew S. Levey, Lesley A. Inker et al. profile →
  8. Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency
    2019 314 citations Andrew S. Levey, Josef Coresh et al. profile →
  9. A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease
    2021 230 citations Cynthia Delgado, Mukta Baweja et al. Journal of the American Society of Nephrology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lesley A. Inker United States 54 7.9k 3.0k 2.3k 1.8k 1.4k 221 14.1k
Hocine Tighiouart United States 57 8.2k 1.0× 3.6k 1.2× 2.2k 1.0× 1.5k 0.8× 2.0k 1.4× 178 14.6k
Bryan Kestenbaum United States 67 8.3k 1.0× 2.7k 0.9× 1.9k 0.8× 2.0k 1.1× 2.2k 1.5× 248 15.6k
Giovanni FM Strippoli Italy 67 6.8k 0.9× 2.3k 0.8× 2.0k 0.9× 1.9k 1.0× 2.5k 1.8× 286 13.9k
Kunitoshi Iseki Japan 58 8.4k 1.1× 2.9k 0.9× 1.5k 0.7× 1.8k 1.0× 2.2k 1.6× 321 13.1k
Rajiv Saran United States 58 7.3k 0.9× 2.4k 0.8× 2.3k 1.0× 1.2k 0.6× 2.1k 1.5× 189 13.9k
Kunihiro Yamagata Japan 43 5.3k 0.7× 2.6k 0.8× 2.3k 1.0× 1.6k 0.9× 1.9k 1.3× 316 12.5k
Morgan E. Grams United States 59 5.4k 0.7× 2.4k 0.8× 2.4k 1.0× 2.1k 1.1× 2.2k 1.6× 330 13.4k
Michel Chonchol United States 62 5.8k 0.7× 2.8k 0.9× 1.7k 0.7× 2.0k 1.1× 2.2k 1.5× 320 14.2k
Stephen L. Seliger United States 53 6.0k 0.8× 4.5k 1.5× 2.1k 0.9× 1.5k 0.8× 1.7k 1.2× 177 12.5k
Dongjie Fan United States 18 6.1k 0.8× 3.4k 1.1× 2.2k 1.0× 1.1k 0.6× 1.8k 1.3× 38 11.1k

Countries citing papers authored by Lesley A. Inker

Since Specialization
Citations

This map shows the geographic impact of Lesley A. Inker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley A. Inker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley A. Inker more than expected).

Fields of papers citing papers by Lesley A. Inker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley A. Inker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley A. Inker. The network helps show where Lesley A. Inker may publish in the future.

Co-authorship network of co-authors of Lesley A. Inker

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley A. Inker. A scholar is included among the top collaborators of Lesley A. Inker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley A. Inker. Lesley A. Inker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heerspink, Hiddo J.L., Lesley A. Inker, Irene de Lourdes Noronha, et al.. (2025). DMX-200 in Patients With Primary Focal Segmental Glomerulosclerosis: Results of the Phase 2 ACTION2 Trial. Kidney International Reports. 10(12). 4272–4276.
2.
Fino, Nora F., Lesley A. Inker, Tom Greene, et al.. (2024). Panel estimated Glomerular Filtration Rate (GFR): Statistical considerations for maximizing accuracy in diverse clinical populations. PLoS ONE. 19(12). e0313154–e0313154. 1 indexed citations
3.
Tangri, Navdeep, Vandana Mathur, David A. Bushinsky, et al.. (2024). VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis. Journal of the American Society of Nephrology. 35(3). 311–320. 7 indexed citations
4.
Ku, Elaine, Lesley A. Inker, Hocine Tighiouart, et al.. (2024). Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease. Annals of Internal Medicine. 177(7). 953–963. 14 indexed citations
5.
Desai, Anant, Lesley A. Inker, Irene de Lourdes Noronha, et al.. (2024). WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS). Kidney International Reports. 9(4). S550–S551.
6.
Xu, Yunwen, Shoshana H. Ballew, Alex R. Chang, et al.. (2024). Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease. Journal of the American Heart Association. 13(16). e034641–e034641. 3 indexed citations
7.
Heerspink, Hiddo J.L., Austin G. Stack, Robert Terkeltaub, et al.. (2024). Combination Treatment with Verinurad and Allopurinol in CKD. Journal of the American Society of Nephrology. 35(5). 594–606. 15 indexed citations
8.
Tighiouart, Hocine, Shiyuan Miao, Marc Froissart, et al.. (2024). Estimating glomerular filtration rate in kidney transplant recipients: considerations for selecting equations. Kidney International. 106(5). 991–995. 1 indexed citations
9.
Fu, Edouard L., Juan Jesús Carrero, Yingying Sang, et al.. (2024). Association of Low Glomerular Filtration Rate With Adverse Outcomes at Older Age in a Large Population With Routinely Measured Cystatin C. Annals of Internal Medicine. 177(3). 269–279. 9 indexed citations
10.
Hall, Rasheeda K., Rümeyza Kazancıoğlu, Teerawat Thanachayanont, et al.. (2024). Drug stewardship in chronic kidney disease to achieve effective and safe medication use. Nature Reviews Nephrology. 20(6). 386–401. 9 indexed citations
11.
El-Khoury, Joe M, Amy B. Karger, Étienne Cavalier, et al.. (2023). International Perspectives on GFR Estimation and Race-Based Adjustments. Clinical Chemistry. 69(8). 796–802. 2 indexed citations
12.
Inker, Lesley A., Hocine Tighiouart, Michael G. Shlipak, et al.. (2023). CKD-EPI and EKFC GFR Estimating Equations: Performance and Other Considerations for Selecting Equations for Implementation in Adults. Journal of the American Society of Nephrology. 34(12). 1953–1964. 25 indexed citations
13.
Hedayati, S. Susan, Amanda R. Vest, Gaurav Gulati, et al.. (2023). Long‐Term Changes in Estimated Glomerular Filtration Rate in Left Ventricular Assist Device Recipients: A Longitudinal Joint Model Analysis. Journal of the American Heart Association. 12(3). e025993–e025993. 1 indexed citations
14.
Xu, Yunwen, Alex R. Chang, Lesley A. Inker, et al.. (2023). Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease. Circulation. 148(19). 1445–1454. 12 indexed citations
15.
Moore, Thomas J., et al.. (2023). Inclusion of Participants with CKD and Other Kidney-Related Considerations during Clinical Drug Development. Clinical Journal of the American Society of Nephrology. 18(4). 455–464. 7 indexed citations
16.
Chang, Alex R., et al.. (2022). Socioeconomic status and use of obesogenic and anti-obesity medications in the United States: A population-based study. The Lancet Regional Health - Americas. 11. 100249–100249. 16 indexed citations
17.
Delgado, Cynthia, Mukta Baweja, Deidra C. Crews, et al.. (2021). A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. Journal of the American Society of Nephrology. 32(12). 2994–3015. 230 indexed citations breakdown →
18.
Grams, Morgan E., et al.. (2021). Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Dipeptidyl Peptidase-4 Inhibitors, and Risk of Hospitalization. The American Journal of Cardiology. 165. 124–130. 9 indexed citations
19.
Levey, Andrew S., Josef Coresh, Hocine Tighiouart, Tom Greene, & Lesley A. Inker. (2019). Measured and estimated glomerular filtration rate: current status and future directions. Nature Reviews Nephrology. 16(1). 51–64. 180 indexed citations
20.
Griffin, Matthew D., Veena S. Rao, James H. Fleming, et al.. (2019). Effect on Survival of Concurrent Hemoconcentration and Increase in Creatinine During Treatment of Acute Decompensated Heart Failure. The American Journal of Cardiology. 124(11). 1707–1711. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hocine Tighiouart Breakdown of academic impact, for papers by Bryan Kestenbaum Breakdown of academic impact, for papers by Giovanni FM Strippoli Breakdown of academic impact, for papers by Kunitoshi Iseki Breakdown of academic impact, for papers by Rajiv Saran Breakdown of academic impact, for papers by Kunihiro Yamagata Breakdown of academic impact, for papers by Morgan E. Grams Breakdown of academic impact, for papers by Michel Chonchol Breakdown of academic impact, for papers by Stephen L. Seliger Breakdown of academic impact, for papers by Dongjie Fan
Rankless by CCL
2026